News

Kamada Expands Plasma Collection with New Houston Center

Kamada Expands Plasma Collection with New Houston Center

Kamada Launches New Plasma Collection Center in Houston

Kamada Ltd., a prominent global biopharmaceutical company, has just opened a cutting-edge plasma collection center in Houston. This launch is part of Kamada's strategy to boost its operational capacity within the specialty plasma-derived sector, which addresses medical conditions that currently lack sufficient treatment options. The new facility is expected to be one of the largest plasma collection sites for specialty treatments in the United States, marking a significant milestone for the company.

New Center Overview

The new center covers 12,000 square feet and includes more than 50 donor beds, enhancing Kamada Plasma's collection capabilities substantially. It is projected to collect around 50,000 liters of plasma each year, potentially generating between $8 million and $10 million in annual revenue when fully operational. Most of this income will come from the collection of normal source plasma, which is vital for various biopharmaceutical uses.

Kamada's Goals for Specialty Plasma Collection

Amir London, Kamada's CEO, stated that the Houston center greatly enhances the company’s vertical integration and its ability to process specialty plasma, including critical products like Anti-Rabies and Anti-D plasma. Gathering these specialized products is essential for patients with specific health issues that require immediate therapeutic solutions.

Plans for Further Expansion

Kamada's expansion plans extend beyond the Houston center. The company is also in the process of developing a third plasma collection site in San Antonio, Texas, which is set to begin operations in the near future. This ongoing growth underlines Kamada's dedication to building a comprehensive network of plasma collection centers throughout the United States, promoting better access to essential plasma-derived therapies for those who need them.

Compliance and Future Approvals

As the Houston facility opens, Kamada is preparing to submit a prior approval supplement to the FDA linked to its current Biologics License Application (BLA). This is a crucial step for ensuring regulatory compliance necessary for the center's full operation. The company also plans to file a plasma master file (PMF) with the European Medicines Agency (EMA), which will support a broader operational strategy in both the U.S. and European markets.

Focus on Innovation and Development

Kamada isn't only focused on immediate goals; they are also investing in a pipeline of innovative therapies aimed at addressing significant medical needs. One key investigational product is an inhaled AAT, specifically designed for treating AAT deficiency. This commitment to innovation marks Kamada as a forward-thinking leader in the biopharmaceutical landscape.

About Kamada

Kamada Ltd. is at the forefront of the biopharmaceutical industry, offering a wide range of products tailored for rare and severe medical conditions. The company prides itself on its ability to deliver vital therapies while consistently pushing the boundaries of research and development. With strategic partnerships and an extensive distribution network across over 30 countries, Kamada ensures that those in need have access to life-saving treatments.

Frequently Asked Questions

What is the purpose of the new plasma collection center in Houston?

The Houston center aims to boost Kamada's ability to collect both specialty and normal source plasma, which are essential for their biopharmaceutical products.

How will the new center affect Kamada's revenue?

Once the center is fully operational, it’s projected to contribute between $8 million and $10 million annually from plasma collection activities.

What types of plasma will the Houston center collect?

This center will collect normal source plasma and various specialty plasma types, including Anti-Rabies and Anti-D products.

Are there plans for additional plasma collection facilities?

Yes, Kamada is also working on a third plasma collection center in San Antonio, Texas.

What is Kamada's focus regarding innovation?

Kamada is dedicated to advancing innovative therapies, particularly for rare diseases and unmet medical needs, while continuing to grow its product portfolio.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Trump's Reagan Forum Speech Puts Defense in Focus Again

Updated Category News Views 118

A December podium in Simi Valley has suddenly become a market-relevant appointment. The Ronald Reagan Presidential Foundation and Institute says President Donald J. Trump will deliver the keynote at the 2026 Reagan National Defense Forum on Friday, December 4, at 3:00 p.m. Pacific time, or 6:00 p.m. Eastern. That is the whole hard fact pattern so far. No agenda, no...

Continue Reading
Childhood Nutrition Advice That Lowers Mealtime Stress

Updated Category News Views 47

A toddler surviving on three bites Tuesday is not a verdict on the family table. That plain idea sits at the center of pediatric expert Kathy Shirazi’s guidance on childhood nutrition, and frankly, it deserves more oxygen than another impossible-looking lunchbox photo. In the HelloNation article released November 20, 2026, Shirazi, MD, MPH, FAAP, urges parents to judge...

Continue Reading
PayPal Adds a Risk Hand to Its Board at a Crucial Turn

Updated Category News Views 91

A Boardroom Hire With Some Actual Weight PayPal did not go hunting for another decorative résumé. Brian J. Lee, set to join the board on November 30, 2026, spent decades inside Goldman Sachs, including a stint as chief risk officer from 2019 through January 2025. For a payments company trying to sharpen its financial-services identity, that is a serious piece of...

Continue Reading
Babe Ruth Lots Lead Morphy's $2 Million Collectibles Auction

Updated Category News Views 61

Ruth still pulls money like few names ever will, and Morphy's November 10-12 auction made that plain without any circus tricks. Three lots tied to the Yankees legend produced $136,500 within a Toys, Sports & General Collectibles sale that topped $2 million. That is not some vague nostalgia story. Buyers put real dollars behind a 1932 U.S. Caramel card, a 1933 Goudey card,...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 55

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 62

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 133

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 113

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
Pompeii Fountain Tests the Value of Concrete Durability

Updated Category News Views 96

Nearly 2,000 nozzles throwing water around a public attraction is a fine way to expose every weak seam in a concrete job. The Fontana Danzante in Pompei, completed in late 2025, is not some quiet decorative basin. It is described as Italy's largest fountain, a nearly 200-meter installation near the Pompeii Archaeological Park that continuously stores, circulates and...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 77

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading

Top 5 Most Recently Viewed Articles

InsCorp, Inc. Experiences Significant Growth Impact in 2025

Updated Category News Views 229

InsCorp, Inc. Sees Improved Financial Metrics in 2025 InsCorp, Inc. (OTCQX: IBTN) has announced results for the second quarter of 2025, demonstrating a noticeable upward trend in earnings per share (EPS) at $0.73, an increase from $0.57 in the prior quarter and $0.63 over the same period last year. Jim Rieniets, the President and CEO of INSBANK, expressed optimism about...

Continue Reading
Revance Celebrates National Sunscreen Day with Times Square Billboard

Updated Category News Views 223

Revance Celebrates National Sunscreen Day with a Bold Message Revance is thrilled to commemorate National Sunscreen Day with a vibrant digital billboard in Times Square. This event not only marks a celebration of Blue Lizard® Australian Sunscreen but also highlights the importance of sun safety as the summer season approaches. Blue Lizard is recognized as the leading...

Continue Reading
Exploring Noah Holdings' Strategic Vision for Global Growth

Updated Category News Views 523

Noah's Global Expansion and Innovative Services Noah Holdings has actively pushed the envelope in providing innovative financial services tailored to meet the diverse wealth management requirements of its clients. This year marks a significant chapter in their journey toward international expansion, where they are introducing groundbreaking solutions along with targeted...

Continue Reading
Streamline Your Taxes: Harness QuickBooks Reports Now

Updated Category News Views 21

QuickBooks: Not Just for Bookkeeping Anymore Taxes can be a pain, but if you're rocking QuickBooks, there's a silver lining. Karen Eberhart Metcalfe, the accounting whiz from Bolingbrook, IL, assures us that this tool isn't merely for ticking boxes in bookkeeping; it's your ace for navigating tax season with less sweat and more precision. When you’ve got those reports...

Continue Reading
Vistra's Options Trading Insights: What Big Investors Indicate

Updated Category News Views 177

Understanding Vistra's Options Trading Landscape Investors are closely observing the options trading activity for Vistra (NYSE: VST) as it indicates a notable bearish sentiment among significant traders. Retail traders would benefit from being aware of these trends. Current Market Sentiment Recent data revealed on options trading history highlights that a recognizable...

Continue Reading